NCT01884519View on ClinicalTrials.gov

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 1, 2013

Primary Completion Date

August 2, 2013

Study Completion Date

August 2, 2013

Conditions
Influenza
Interventions
BIOLOGICAL

Fluarix/Influsplit SSW® (2013-2014 season)

1 dose administered intramuscularly (or deeply subcutaneously) in the deltoid region of the non-dominant arm

Trial Locations (4)

01307

GSK Investigational Site, Dresden

09599

GSK Investigational Site, Freiberg

01705

GSK Investigational Site, Freital

01762

GSK Investigational Site, Schmiedeberg

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY